◼ Archived
Business
🔮 fades ✓
EyePoint Stock Craters 69% After Drug Trial Failure. It May Be an Overreaction.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
3 trends tracked about this subject — the full history, oldest to newest below.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
9 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
SK Hynix’s weak outlook triggers a memory‑chip sell‑off and fuels debate over a possible end to the AI‑driven boom.